Cerebral amyloid angiopathy (CAA) is characterized by the deposition of amyloid aggregates in the walls of the cerebral vasculature. Recently, the development of molecular imaging probes targeting CAA has been attracting much attention. Tc]MBT2 showed very low brain uptake, which is favorable for CAA-specific imaging. An in vitro inhibition assay using β-amyloid aggregates and in vitro autoradiographic examination of brain sections from a Tg2576 mouse and a CAA patient showed a decline in the binding affinity for amyloid aggregates due to N-methylation of the 99m Tc-Ham complex. These results suggest that the scaffold of the 99m Tc-Ham complex may play important roles in the in vitro stability and the binding affinity for amyloid aggregates.
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Introduction
Cerebral amyloid angiopathy (CAA) is defined as the deposition of amyloid aggregates, most commonly β-amyloid peptide (Aβ), in the media and adventitia of arteries and, less often, capillaries of the brain [1] [2] [3] . CAA is a sporadic or familial disorder and is common in the elderly brain, with an age-related prevalence and significant increase with age [4] . CAA is present in nearly all Alzheimer's disease (AD) brains [4] , and severe CAA is present in approximately 25% of AD brains [5] , while fewer than 50% of CAA cases meet the pathologic criteria for AD [6] . CAA can cause fatal intracerebral hemorrhage (ICH) and vascular cognitive impairment [3, 7, 8] , and is also associated with small vessel diseases such as white matter hyperintensity and cerebral microbleeds [3, 9, 10] .
A definitive CAA diagnosis can be performed based on only histological findings of brain tissue, obtained by autopsy or brain biopsy [11] . Although computed tomography (CT) and magnetic resonance imaging (MRI) without any probe have commonly been used as noninvasive and useful modalities to diagnose CAA-associated ICH [12, 13] , they detect intracerebral bleeding as a surrogate marker of CAA. These indirect diagnostic techniques cannot shed light on the etiology of the sign, making it unlikely to perform disease-specific diagnoses. In contrast, positron emission tomography (PET) and single photon emission computed tomography (SPECT) can provide information on the localization of amyloid aggregates, while CT and MRI provide the anatomical information. Therefore, PET and SPECT have been utilized as major in vivo imaging techniques to carry out the noninvasive diagnosis of amyloidoses. Over the past few decades, research on imaging of Aβ aggregates constituting senile plaque in AD brains using PET and SPECT tracers has made marked progress [14] [15] [16] [17] [18] [19] .
Several groups have reported on the detection of cerebrovascular amyloid depositions using [ 11 C]PIB, which is the most commonly used Aβ-imaging probe [20] [21] [22] . However, due to highlevel efficiency with the penetration of the blood-brain barrier (BBB), [ 11 C]PIB is believed to visualize amyloid depositions in the whole brain, indicating that it detects senile plaque as a background signal in cases of CAA diagnosis.
With the aim of CAA-specific imaging, some groups, in addition to our group, have reported PET and SPECT imaging probes targeting CAA [23] [24] [25] [26] [27] (Fig 1) .
Materials and Methods

General
All reagents were obtained commercially and used without further purification unless otherwise indicated. PIB was purchased from ABX (Saxony, Germany). Na Tc generator (Ultra-Techne Kow; FUJIFILM RI Pharma Co., Ltd., Tokyo, Japan). W-Prep 2XY (Yamazen, Osaka, Japan) was used for silica gel column chromatography on a Hi Flash silica gel column (40 μm, 60 Å, Yamazen, Osaka, Japan). 1 triplet (t), or multiplet (m). Mass spectra were obtained on a SHIMADZU LCMS-2020 (SHIMADZU, Kyoto, Japan). Reversed-phase high-performance liquid chromatography (RP-HPLC) was performed with a Shimadzu system (SHIMADZU, an LC-20AT pump with an SPD-20A UV detector, λ = 254 nm) with a Cosmosil C 18 column (Nacalai Tesque, Kyoto, Japan, 5C 18 -AR-II, 4.6 × 150 mm) using a mobile phase [10 mM phosphate buffer (pH 7.4)/ acetonitrile = 3/2 (0 min) to 3/7 (30 min)] delivered at a flow rate of 1.0 mL/min.
Animals
Animal experiments were conducted in accordance with our institutional guidelines and were approved by the Kyoto University Animal Care Committee. Male ddY mice were purchased from Japan SLC, Inc. (Shizuoka, Japan). Female Tg2576 mice and wild-type mice were purchased from Taconic Farms, Inc. (New York, USA). Animals were fed standard chow and had free access to water. All efforts were made to minimize suffering.
Human brain tissues
Experiments involving human subjects were performed in accordance with the relevant guidelines and regulations and were approved by the ethics committee of Kyoto University. Informed consent was obtained from all subjects in this study. Postmortem brain tissues from autopsyconfirmed cases of CAA (female, 67 years old) were obtained from the Graduate School of Medicine, Kyoto University.
Compound 1 was prepared according to our previous report [30] . 
To a solution of 1 (50 mg, 0.16 mmol) in DMF (10 mL) were added ethyl chlorocarbonate (18 μL, 0.19 mmol) and triethylamine (44 μL, 0.32 mmol). The reaction mixture was stirred at room temperature for 1 h. Water (50 mL) was added, and the mixture was extracted with chloroform (30 mL × 2). The organic layers were combined, dried over MgSO 4 , and filtered. Evaporation of the filtrate gave a residue, which was purified by silica gel chromatography (ethyl acetate/hexane = 10/1) to give 16 mg of 2 (25% yield). 
A solution of 2 (87 mg, 0.23 mmol) in 1 M NaOH (aq)/DMF (1/1, 40 mL) was stirred at room temperature for 1 h. After the addition of acetate (5 mL), the mixture was neutralized with saturated NaHCO 3 water (20 mL), and extracted with chloroform (50 mL × 2). The organic layers were combined, dried over MgSO 4 , and filtered. Evaporation of the filtrate gave a residue, which was purified by silica gel chromatography (ethyl acetate/hexane = 5/1) to give 15 mg of 3 (20% yield).
1 H NMR (400 MHz, DMSO-
Iodomethane (5.5 μL, 0.088 mmol) and potassium carbonate (18 mg, 0.13 mmol) were added to a solution of 3 (15 mg, 0.044 mmol) in DMF (5 mL). The reaction mixture was stirred at room temperature for 3 h. After the addition of water (50 mL), the mixture was extracted with chloroform (30 mL × 2). The organic layers were combined, dried over MgSO 4 , and filtered. Evaporation of the filtrate gave a residue, which was purified by silica gel chromatography (ethyl acetate/hexane = 1/1) to give 9 mg of 4 (58% yield). A solution of 4 (15 mg, 0.043 mmol) in 1 M NaOH (aq)/DMF (1/1, 10 mL) was stirred at 90°C for 14 h. The reaction mixture was neutralized with 1 M HCl (aq) while it was cooled in an ice bath. After extraction with chloroform, the organic layers were combined, dried over MgSO 4, and filtered. The filtrate was concentrated, and the residue was purified by silica gel chromatography (chloroform/methanol = 10/1) and then RP-HPLC [10 mM phosphate buffer (pH 7.4)/acetonitrile = 3/2 (0 min) to 3/7 (30 min)] to give 5 mg of 5 (36% yield). 1 
Stability in murine plasma
The 99m Tc-Ham complex (740 kBq) was added to freshly prepared murine plasma (200 μL) collected from ddY mice (male, 5 weeks old). After incubating the solution at 37°C for 0.5, 1, and 2 h, acetonitrile (200 μL) was added. Subsequently, they were centrifuged (4,000 g, 5 min), and the supernatant was analyzed by RP-HPLC.
Assessment of the BBB permeability
A saline solution (100 μL) of the 99m Tc-Ham complex (20 kBq) containing EtOH (10 μL) was injected directly into the tail vein of ddY mice (male, 5 weeks old). The mice were sacrificed at 2, 10, 30, and 60 min postinjection. The brain was removed and weighed, and radioactivity was measured using a γ counter (Wallac 1470 Wizard; PerkinElmer, Massachusetts, USA). The % injected dose (ID)/g of samples was calculated by comparing the sample counts with the count of the diluted initial dose.
Inhibition assay using Aβ aggregates in solution
A solid form of Aβ(1-42) was purchased from the Peptide Institute (Osaka, Japan). Aggregation was carried out by gently dissolving the peptide (0.25 mg/mL) in phosphate-buffered saline (PBS) (pH 7.4). The solution was incubated at 37°C for 42 h with gentle and constant shaking. A mixture containing 50 μL of Aβ(1-42) aggregates (final conc., 1.25 μg/mL), 50 μL of the 99m Tc-Ham complex (8 kBq), 50 μL of PIB (final conc., 64 pM-125 μM in EtOH), and 850 μL of 30% EtOH was incubated at room temperature for 3 h. The mixture was filtered through Whatman GF/B filters (Whatman, Kent, U.K.) using a Brandel M-24 cell harvester (Brandel, Maryland, USA), and the radioactivity of the filters containing the bound 99m TcHam complex was measured using a γ counter (Wallac 1470 Wizard). Values for the half-maximal inhibitory concentration (IC 50 ) were determined from displacement curves using GraphPad Prism 5.0 (GraphPad Software, Inc., California, USA).
In vitro autoradiography of Tg2576 mouse brain sections
A Tg2576 transgenic mouse (female, 28 months old) and a wild-type mouse (female, 28 months old) were used as an AD model and an age-matched control, respectively. After each animal had been sacrificed by decapitation, the brain was immediately removed, embedded in Super Cryoembedding Medium (SCEM) compound (SECTION-LAB Co., Ltd., Hiroshima, Japan), and then frozen in a dry ice/hexane bath. Frozen sections were prepared at a 10-μm thickness. Each slide was incubated with a 50% EtOH solution of the 99m Tc-Ham complex (370 kBq/mL) at room temperature for 1 h. For blocking experiments, adjacent sections were incubated with a 50% EtOH solution of the 99m Tc-Ham complex (370 kBq/mL) in the presence of nonradioactive PIB (500 μM). The sections were washed in 50% EtOH for 1.5 min two times and exposed to a BAS imaging plate (Fuji Film, Tokyo, Japan) for 6 h. Autoradiographic images were obtained using a BAS5000 scanner system (Fuji Film). After autoradiographic examination, the same sections were stained by thioflavin-S to confirm the presence of Aβ plaques. For thioflavin-S staining, the sections were immersed in a 100 μM thioflavin-S solution containing 50% EtOH for 3 min, washed in 50% EtOH for 1 min two times, and examined using a microscope (BIOREVO BZ-9000; Keyence Corp., Osaka, Japan) equipped with a GFP-BP filter set.
In vitro autoradiography of human CAA brain sections
Six-micrometer-thick serial human brain sections of paraffin-embedded blocks were used for autoradiography. To completely deparaffinize the sections, they were incubated in xylene for 30 min two times and in 100% EtOH for 1 min two times. Subsequently, they were subjected to 1-min incubation in 90% EtOH and 1-min incubation in 70% EtOH, followed by a 5-min wash in water. Each slide was incubated with a 50% EtOH solution of the 99m Tc-Ham complex (370 kBq/mL) at room temperature for 1 h. The sections were washed in 50% EtOH for 3 min two times and exposed to a BAS imaging plate (Fuji Film) for 2 h. Autoradiographic images were obtained using a BAS5000 scanner system (Fuji Film). After autoradiographic examination, the adjacent section was immunostained by an antibody against Aβ(1-40) to confirm the presence of Aβ depositions. For immunohistochemical staining of Aβ(1-40), the section was autoclaved for 15 min in 0.01 M citric acid buffer (pH 6.0) to activate the antigen. After three 5-min incubations in PBS-Tween 20 (PBST), it was incubated with anti-Aβ(1-40) primary antibody (BA27; Wako, Osaka, Japan) at room temperature overnight. Subsequently, it was incubated in PBST for 5 min three times, and incubated with biotinylated goat anti-mouse IgG (Wako) at room temperature for 3 h. After three 5-min incubations in PBST, the section was incubated with Streptavidin-Peroxidase complex at room temperature for 30 min. After three 5-min incubations in PBST, it was incubated with diaminobenzidine (Merck, Hesse, Germany) as a chromogen for 5 min. After washing with water, the section was observed under a microscope (BIOREVO BZ-9000).
Results and Discussion Chemistry
The precursor for [ (Fig 2)[31] . BTHam was prepared according to our previous report [30] . Reaction of BTHam with ethyl chlorocarbonate provided compound 2, which was cyclized to compound 3 in alkaline solution. After methylation with iodomethane to give compound 4, it was decyclized by heating in alkaline solution to MBTHam.
Radiolabeling
The 99m
Tc labeling reaction was performed by the complexation reaction using the Ham precursor, 99m Tc-pertechnetate, and tin(II) tartrate hydrate as a reducing agent (Fig 3)[30] . The Tc complexation reaction with MBTHam rendered a single peak at the retention time of 13.6 min on RP-HPLC, while the reaction with BTHam provided two peaks at the retention times of 11.5 and 14.3 min (Fig 4) . This suggests that N-methylation of the Ham ligand would be a useful strategy to obtain a single 99m Tc-Ham complex by preventing the isomerism, as described in a previous report [29] . We defined the specific isomer of [ 
Stability in murine plasma
The in vitro stability of [ Tc-Ham complex enhanced its stability, as demonstrated in a previous report [29] .
Assessment of the BBB permeability
Biodistribution experiments were performed in order to assess the brain uptake of [ 99m Tc] MBT2 in normal mice (Table 2 ). To reduce the binding to Aβ aggregates in the brain cortex, CAA-specific imaging probes need not to show high-level penetration of the BBB [28, 29] . Tc-complexes was expressed as values for the half-maximal inhibitory concentration (IC 50 ) determined from displacement curves (Fig 6) Tc]BT2 to Aβ plaques in brain sections from Tg2576 mice was evaluated by in vitro autoradiography. Since Tg2576 mice overproduce Aβ aggregates in the brain, they have been commonly used to evaluate the specific binding affinity of probes for Aβ aggregates in a variety of experiments in vitro and in vivo [19, 28, 30] . As shown in (Fig 7B, 7F and 7J ). These radioactive spots were consistent with Aβ depositions confirmed by the fluorescent staining in the same sections with thioflavin-S, a dye commonly used to stain Aβ plaques (Fig 7C, 7G and 7K, red arrowheads) . However, some Aβ depositions were not labeled with [ Tc-labeled compounds was blocked to a large extent with an excess of nonradioactive PIB, confirming the specific binding to Aβ plaques in the mouse brain (Fig 7D, 7H and 7L) . A decline in the binding affinity for Aβ plaques by chemical modification of the 99m Tc-Ham complex was suggested in autoradiograms, as observed in the inhibition assay.
Inhibition assay using Aβ aggregates in solution
In vitro autoradiography of human CAA brain sections
An in vitro autoradiographic examination of human CAA brain sections was carried out in order to confirm binding affinity for Aβ plaques deposited in the human brain (Fig 8) . The distribution of Aβ deposits was confirmed by immunohistochemical staining of Aβ (Fig 8B) , showing that [ 99m Tc]MBT2 moderately labeled Aβ deposits in a brain section from a CAA patient. However, as observed in the inhibition assay and autoradiographic examination using 
Conclusions
Herein, we designed and synthesized a novel N-methyl-substituted 
